Pro-Dex (PDEX) Expected to Announce Quarterly Earnings on Thursday

Pro-Dex (NASDAQ:PDEX - Get Free Report) is projected to announce its Q3 2025 earnings results before the market opens on Thursday, May 1st. Analysts expect the company to announce earnings of $0.47 per share and revenue of $17.70 million for the quarter.

Pro-Dex (NASDAQ:PDEX - Get Free Report) last issued its quarterly earnings data on Thursday, January 30th. The medical instruments supplier reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.23. Pro-Dex had a return on equity of 21.68% and a net margin of 11.06%. On average, analysts expect Pro-Dex to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Pro-Dex Price Performance

Shares of PDEX stock traded down $2.03 on Friday, reaching $64.89. The company's stock had a trading volume of 54,417 shares, compared to its average volume of 25,827. The company has a market capitalization of $211.61 million, a price-to-earnings ratio of 32.28 and a beta of 0.40. The stock's fifty day simple moving average is $49.21 and its 200-day simple moving average is $44.45. The company has a current ratio of 2.58, a quick ratio of 1.44 and a debt-to-equity ratio of 0.33. Pro-Dex has a 1 year low of $16.84 and a 1 year high of $70.26.

Insider Transactions at Pro-Dex

In other news, Director Raymond E. Cabillot sold 842 shares of the stock in a transaction that occurred on Friday, March 28th. The stock was sold at an average price of $50.00, for a total value of $42,100.00. Following the sale, the director now directly owns 278,945 shares in the company, valued at approximately $13,947,250. This represents a 0.30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In the last quarter, insiders sold 27,864 shares of company stock worth $1,304,758. 47.50% of the stock is currently owned by insiders.

Analyst Ratings Changes

Separately, StockNews.com cut Pro-Dex from a "buy" rating to a "hold" rating in a research note on Wednesday, March 12th.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.